Browsing Tag
Anew Labs
1 post
ByteDance AI drug spin-off Anew Labs secures $290m at $1.5bn valuation
ByteDance’s artificial-intelligence drug discovery spin-off Anew Labs has completed a $290 million external financing at a reported $1.5 billion valuation, attracting leading Chinese investment firms while leaving ByteDance with a controlling 56% stake.
September 16, 2026